A comparison of granisetron, droperidol, and metoclopramide in the treatment of established nausea and vomiting after breast surgery: A double-blind, randomized, controlled trial

Clinical Therapeutics

Volumn 25, Issue 4, 2003, Pages 1142-1149

  Fujii, Yoshitaka ^a,b   Tanaka, Hiroyoshi ^a   Kawasaki, Tsuneo ^a  

^a Toride Kyodo General Hospital   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Antiemetics; Breast; Droperidol; Granisetron; Metoclopramide; Nausea; Vomiting

Indexed keywords

ANTIEMETIC AGENT; DROPERIDOL; GRANISETRON; METOCLOPRAMIDE; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ANESTHESIA; ARTICLE; BREAST SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL;

EID: 0037732784     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80072-3     Document Type: Article

References (13)

1. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992;77:162-184.
2. Jakobsson J, Andersson L, Nilsson A, et al. Premedication before elective breast surgery, a comparison between ketobemidone and midazolam. Acta Anaesthesiol Scand. 1991;35:524-528.
3. Oddby-Muhrbeck E, Jakobsson A, Andersson L, Askergren J. Postoperative nausea and vomiting. A comparison between intravenous and inhalation anaesthesia in breast surgery. Acta Anaesthesiol Scand. 1994;38:52-56.
4. McKenzie R, Kovac A, O'Connor T, et al. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology. 1993;78:21-28.
5. Diemunsch P, Conseiller C, Clyti N, Mamet JP, for the French Ondansetron Study Group. Ondansetron compared with metoclopramide in the treatment of established postoperative nausea and vomiting. Br J Anaesth. 1997;79:322-326.
6. 3 receptor antagonists the same? Eur J Cancer. 1992;28A(Suppl 1):S2-S6.
7. Fujii Y, Tanaka H, Toyooka H. Granisetron reduces incidence of nausea and vomiting after breast surgery. Acta Anaesthesiol Scand. 1997;41:746-749.
8. Fujii Y, Tanaka H, Toyooka H. Effective dose of granisetron in the reduction of nausea and vomiting after breast surgery. Acta Anaesthesiol Scand. 1997;41:1167-1170.
9. 3 receptor antagonist BRL 43694. Br J Cancer. 1988;58:644-650.
10. Furue H, Oota K, Taguchi T, Niitani H. Clinical evaluation of granisetron against nausea and vomiting by induced anticancer drugs. I. Optimal dose-finding study [in Japanese]. J Clin Ther Med. 1990;6(Suppl 5):49-61.
11. 3 receptor antagonist: Correlation of anti-emetic response. Cancer Chemother Pharmacol. 1989;24:45-49.
12. Yarker YE, McTavish D. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs. 1994;48:761-793.
13. McCormick CG. FDA alert: Current FDA report on droperidol status and basis for "Black Box" warning. ASA Newsl. 2002;66:19.